Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Walter M. Stadler

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Stadler, Walter

PropertyValue
keywords Renal Cancer
overview Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research

One or more keywords matched the following items that are connected to Stadler, Walter

Item TypeName
Concept Kidney Neoplasms
Academic Article High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience.
Academic Article Human renal cancer carcinogenesis: a review of recent advances.
Academic Article Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.
Academic Article Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator.
Academic Article A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.
Academic Article Cytokine therapy in metastatic renal cancer.
Academic Article Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
Academic Article Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
Academic Article Kidney cancer.
Academic Article Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
Academic Article Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Academic Article Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Academic Article A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.
Academic Article Renal cancer immunotherapy: a ray of hope or regression to the mean?
Academic Article Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.
Academic Article A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer.
Academic Article Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Academic Article A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Academic Article Acute bilateral abducens paralysis due to oxaliplatin.
Academic Article Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.
Academic Article Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Academic Article Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Academic Article Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.
Academic Article Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.
Academic Article Randomized discontinuation design: application to cytostatic antineoplastic agents.
Academic Article Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
Academic Article Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Academic Article The role of systemic chemotherapy in the treatment of kidney cancer.
Academic Article Cytotoxic chemotherapy for metastatic renal cell carcinoma.
Academic Article Targeted agents for the treatment of advanced renal cell carcinoma.
Academic Article Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Academic Article Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.
Academic Article A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
Academic Article A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
Academic Article Sorafenib in advanced clear-cell renal-cell carcinoma.
Academic Article Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article Multiple reference tissue method for contrast agent arterial input function estimation.
Academic Article Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Academic Article Innovations and challenges in renal cancer: consensus statement from the first international conference.
Academic Article Therapeutic options for variant renal cancer: a true orphan disease.
Academic Article Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Academic Article Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
Academic Article Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy.
Academic Article Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.
Academic Article Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.
Academic Article A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Academic Article Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
Academic Article A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.
Academic Article New therapeutic options for renal cell carcinoma.
Academic Article Sorafenib.
Academic Article Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
Academic Article Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America.
Academic Article A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Academic Article Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses.
Academic Article Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program.
Academic Article Prognostic factors in localized renal cell cancer.
Academic Article Bevacizumab and everolimus in renal cancer: a rational way forward.
Academic Article A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Academic Article Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206.
Academic Article Effective therapy for metastatic renal cancer, whither to now.
Academic Article A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
Academic Article Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Academic Article Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article Pazopanib in renal cell carcinoma.
Academic Article Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Academic Article Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.
Academic Article Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Academic Article A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.
Academic Article A molecular classification of papillary renal cell carcinoma.
Academic Article Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Academic Article A phase II study of depsipeptide in refractory metastatic renal cell cancer.
Academic Article Angiogenesis inhibition in non-clear cell renal cancer.
Academic Article Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.
Academic Article A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
Academic Article Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article Renal cancer therapeutics: now what?
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.
Academic Article Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
Academic Article Predictive markers in advanced renal cell carcinoma.
Academic Article Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Academic Article A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.
Academic Article Maturing of renal cancer therapeutics.
Academic Article FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
Academic Article Optimal use of imaging to guide treatment decisions for kidney cancer.
Academic Article Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?
Academic Article First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70.
Academic Article Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Academic Article Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Academic Article Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Academic Article Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.
Academic Article Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Academic Article Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Academic Article Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Academic Article Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.
Academic Article The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Academic Article Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.

Search Criteria
  • Renal Cancer